FindTrial
Sign In

Association of urinary podocyte marker protein with type 2 diabetic nephropathy

Association of urinary podocyte marker protein with type 2 diabetic nephropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026547
Enrollment
Unknown
Registered
2019-10-13
Start date
2019-10-15
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

microalbuminuria group:N/A
massive proteinuria group:N/A
Healthy control group:N/A

Sponsors

People's Hospital of Suzhou New District
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the diagnostic criteria for type 2 diabetes and Mogensen staging criteria for diabetic nephropathy established by WHO in 1999, 100 patients with type 2 diabetes mellitus complicated with diabetic nephropathy were screened from the community population of Suzhou new district. The patients were further divided into microalbuminuria group (urinary albumin excretion rate 30-300 mg/24 h) and macroalbuminuria group (urinary albumin excretion rate > 300 mg/24 h). At the same time, 30 healthy people were compared.

Exclusion criteria

Exclusion criteria: Patients combined with autoimmune diseases, acute or chronic inflammatory or infectious diseases, trauma, tumors, dialysis or kidney transplantation should be excluded from the group.

Design outcomes

Primary

MeasureTime frame
Age;Gender;Weight;Blood pressure;Duration of diabetes mellitus;Diabetic Retinopathy;Urine PCX;—

Countries

China

Contacts

Public ContactXie Yuxian

People's Hospital of Suzhou New District

yuxianxie1970@126.com+86 15250427092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026